Following are six reasons why pharmaceutical and life sciences companies must prioritize track-and-trace technology in their ...
This link in the pharma supply chain is undergoing a major transformation propelled by technological advancements, regulatory ...
The potential applications of artificial intelligence (AI) in biopharmaceuticals appear wide-ranging and transformative.
The pharmaceutical industry faces significantly longer lead times than other industries, and time delays can seriously impact the health outcomes of countless individuals. Recognizing the potential ...
Generic drugmakers and hospital pharmacists warn that added financial pressure from tariffs could strain the nation's generic drug supplies.
4d
Pharmaceutical Technology on MSNAmid deglobalising trade, experts seek AI safeguards for clinical trial supplyThe role of AI in supply chain management proved to be the focal issue at the recent 2025 Clinical Trial Supply Europe ...
12h
The Punch on MSNFake drugs kill thousands, yet offenders walk free – Pharmaceutical society president, AyubaFor the public, I would advise that when purchasing drugs or medication, they should buy only from registered pharmacies.
A bipartisan, bicameral group of senators have introduced legislation that would give the president new authority to ...
Indian pharma companies are expanding in the US through acquisitions to navigate regulations, diversify portfolios, and ...
Teva Hong Kong ('Teva'), has announced a strategic partnership with Kerry Pharma, the subsidiary of Kerry Logistics Network ...
Ron Lanton, Partner, Lanton Law, examines the legal and economic impacts of reciprocal tariffs on the pharma supply chain, including potential disruptions and increased drug costs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results